	US 11,971,412 B2
	Polypeptide-antibody complexes and uses thereof
Wendy K. Nevala, Rochester, MN (US); Svetomir N. Markovic, Rochester, MN (US); John T. Butterfield, Edina, MN (US); and Daniel J. Knauer, Costa Mesa, CA (US)
Assigned to MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Rochester, MN (US)
Filed by Mayo Foundation for Medical Education and Research, Rochester, MN (US)
Filed on Nov. 8, 2022, as Appl. No. 18/053,711.
Application 18/053,711 is a continuation of application No. 16/603,466, granted, now 11,531,030, previously published as PCT/US2018/028557, filed on Apr. 20, 2018.
Claims priority of provisional application 62/626,790, filed on Feb. 6, 2018.
Claims priority of provisional application 62/488,392, filed on Apr. 21, 2017.
Prior Publication US 2023/0273212 A1, Aug. 31, 2023
Int. Cl. G01N 33/574 (2006.01); C07K 14/00 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01)

CPC G01N 33/5748 (2013.01) [C07K 14/001 (2013.01); C07K 16/2827 (2013.01); C07K 16/2887 (2013.01); C07K 16/32 (2013.01); G01N 33/57492 (2013.01)]

20 Claims

1. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO:10, or comprising the amino acid sequence of SEQ ID NO:10 but with one or two amino acid deletions, additions, or substitutions within the C-terminal five amino acids of SEQ ID NO:10.